RBREW Share Price Performance
DKK 486.40
-35.10 (-6.73%)
17.9% undervalued intrinsic discount
DKK 592.26
Fair Value
Price DKK 486.40
AnalystConsensusTarget DKK 592.26
Fair ValueDKK 592.26
Share PriceDKK 486.40
17.9% undervalued intrinsic discount
RBREW Community Narratives
AN
Fair Value DKK 592.26 17.9% undervalued intrinsic discount
European Expansion And Focus On Healthy Beverages Will Create New Opportunities
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
RBREW Community Fair Values
- DKK 592.26FV17.9% undervalued intrinsic discount4.86%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative10users have followed this narrative7 days ago author updated this narrative
Recent RBREW News & Updates
No updates
Royal Unibrew A/S Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 26, 2025
- Earnings per share (EPS)
- 30.05
- Gross Margin
- 42.74%
- Net Profit Margin
- 9.91%
- Debt/Equity Ratio
- 100.5%
Royal Unibrew A/S Competitors
About RBREW
- Founded
- 1989
- Employees
- 4365
- CEO
- WebsiteView website
Royal Unibrew A/S provides beer, soft drinks, malt beverages, energy drinks, cider/ready to drink, juice, water, and wine and spirits. It offers its products under the Royal Beers, Lapin Kulta, Cido, Faxe Kondi, Ceres, Faxe, Original Long Drink, Lacplesis, Vitamalt, Mangali, Novelle, Nikoline, Kalnapilis, Egekidle, Supermalt, Polar Monkeys, Lorina, SHAKER, MOKAI, LemonSoda, Nohrlund, Power Malt, Fonti di Crodo, CULT, Lahden Erikois, Vilkmerges, and Lielvardes brands, as well as partnership with brands, such as Heineken and PepsiCo. It serves customers in Denmark, Germany, Norway, Sweden, Italy, the Netherlands, France, Finland, Lithuania, Latvia, Estonia, Belgium, Luxembourg, and internationally. The company was formerly known as Bryggerigruppen A/S and changed its name to Royal Unibrew A/S in 2005. Royal Unibrew A/S was incorporated in 1989 and is headquartered in Faxe, Denmark.
Danish Market Performance
- 7 Days: -6.2%
- 3 Months: -12.2%
- 1 Year: -40.6%
- Year to Date: -28.3%
Over the last 7 days, the market has dropped 6.2%, driven by a decline of 10% in the Healthcare sector. In the last 12 months the market is down 41%. As for the next few years, earnings are expected to grow by 6.5% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading